Supreme Court Shuts Down 'Skinny Label' Drug Patent Suit
The U.S. Supreme Court on Thursday ended a patent suit over Hikma Pharmaceuticals USA Inc.'s generic version of a heart drug that uses a so-called skinny label, saying Amarin Pharma Inc....To view the full article, register now.
Already a subscriber? Click here to view full article